Cargando…
Exploiting the neoantigen landscape for immunotherapy of pancreatic ductal adenocarcinoma
Immunotherapy approaches for pancreatic ductal adenocarcinoma (PDAC) have met with limited success. It has been postulated that a low mutation load may lead to a paucity of T cells within the tumor microenvironment (TME). However, it is also possible that while neoantigens are present, an effective...
Autores principales: | Bailey, Peter, Chang, David K., Forget, Marie-Andrée, Lucas, Francis A. San, Alvarez, Hector A., Haymaker, Cara, Chattopadhyay, Chandrani, Kim, Sun-Hee, Ekmekcioglu, Suhendan, Grimm, Elizabeth A., Biankin, Andrew V., Hwu, Patrick, Maitra, Anirban, Roszik, Jason |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5071896/ https://www.ncbi.nlm.nih.gov/pubmed/27762323 http://dx.doi.org/10.1038/srep35848 |
Ejemplares similares
-
Cervical Cancer Neoantigen Landscape and Immune Activity is Associated with Human Papillomavirus Master Regulators
por: Qin, Yong, et al.
Publicado: (2017) -
Targeting iNOS to increase efficacy of immunotherapies
por: Ekmekcioglu, Suhendan, et al.
Publicado: (2017) -
Identification of predictive biomarker signatures in melanoma tumors associated with response to tumor-infiltrating lymphocyte (TIL) therapy
por: Chen, Jie Qing, et al.
Publicado: (2013) -
Impact of l-Arginine Metabolism on Immune Response and Anticancer Immunotherapy
por: Kim, Sun-Hee, et al.
Publicado: (2018) -
Editorial: Targeting Metabolism in Cancer Immunotherapy
por: Roszik, Jason, et al.
Publicado: (2018)